Mid-Term Natural Course Postoperative of Crowe Type III-IV Hip Dysplasia
Mid-Term Natural Course of Lower Extremity and Spine After Total Hip Arthroplasty in Patients With Crowe Type III-IV Hip Dysplasia
1 other identifier
interventional
20
1 country
1
Brief Summary
Comparison of preoperative and postoperative mid-term course of patients with Crowe Type 3 and Type 4 hip dysplasia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2021
CompletedFirst Submitted
Initial submission to the registry
October 8, 2021
CompletedFirst Posted
Study publicly available on registry
December 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2024
CompletedDecember 8, 2021
December 1, 2021
3.2 years
October 8, 2021
December 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
The WOMAC score range, which indicates the clinical satisfaction of the patients, is between 0-100.
The degree of improvement in Vomac score will be evaluated by looking at preoperative and postoperative 12th month Vomac scores.( 0-12th month )
Study Arms (1)
Crowe type 3 and 4 patients undergoing shortened hip replacement
EXPERIMENTALClinical and radiological results of Crowe type 3 and 4 patients who underwent shortened hip prosthesis at 12 and 24 months
Interventions
Crowe type 3 and 4 patients who underwent shortened hip prosthesis
Eligibility Criteria
You may qualify if:
- Crowe type 3 and 4 patients over 18 years of age who had shortened hip replacement surgery
You may not qualify if:
- Crowe type 1 or 2 patients over 18 years of age who had shortened hip replacement surgery
- Patients who have previously operated on the contralateral hip
- Patients who underwent shortened hip replacement for a reason other than developmental dysplasia of the hip
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bezmialem Vakıf University
Istanbul, Fatih, 34500, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Gökçer Uzer
Bezmialem Vakif University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopaedic surgeon
Study Record Dates
First Submitted
October 8, 2021
First Posted
December 8, 2021
Study Start
February 10, 2021
Primary Completion
May 10, 2024
Study Completion
June 10, 2024
Last Updated
December 8, 2021
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share